Neuland Laboratories Statistics

Total Valuation

Neuland Laboratories has a market cap or net worth of INR 160.00 billion. The enterprise value is 160.08 billion.

Market Cap	160.00B
Enterprise Value	160.08B

Important Dates

The next estimated earnings date is Thursday, October 31, 2024.

Earnings Date	Oct 31, 2024
Ex-Dividend Date	Jul 12, 2024

Share Statistics

Shares Outstanding	n/a
Shares Change (YoY)	-0.01%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	7.01M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	9.72
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	47.63
EV / Sales	9.79
EV / EBITDA	32.84
EV / EBIT	37.48
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	7.44
Debt / EBITDA	0.20
Debt / FCF	n/a
Interest Coverage	37.04

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	21.35%
Revenue Per Employee	9.95M
Profits Per Employee	2.05M
Employee Count	1,643
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +226.92% in the last 52 weeks. The beta is 1.05, so Neuland Laboratories's price volatility has been similar to the market average.

Beta (5Y)	1.05
52-Week Price Change	+226.92%
50-Day Moving Average	11,417.70
200-Day Moving Average	7,701.74
Relative Strength Index (RSI)	50.56
Average Volume (20 Days)	25,653

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Neuland Laboratories had revenue of INR 16.35 billion and earned 3.36 billion in profits. Earnings per share was 261.94.

Revenue	16.35B
Gross Profit	8.72B
Operating Income	4.27B
Pretax Income	4.48B
Net Income	3.36B
EBITDA	4.84B
EBIT	4.27B
Earnings Per Share (EPS)	261.94

Full Income Statement

Balance Sheet

The company has 875.75 million in cash and 953.90 million in debt, giving a net cash position of -78.14 million.

Cash & Cash Equivalents	875.75M
Total Debt	953.90M
Net Cash	-78.14M
Net Cash Per Share	n/a
Equity (Book Value)	12.83B
Book Value Per Share	999.78
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 53.32%, with operating and profit margins of 26.12% and 20.55%.

Gross Margin	53.32%
Operating Margin	26.12%
Pretax Margin	27.40%
Profit Margin	20.55%
EBITDA Margin	29.61%
EBIT Margin	26.12%
FCF Margin	n/a

Dividends & Yields

Neuland Laboratories does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	40.00%
Years of Dividend Growth	2
Payout Ratio	n/a
Buyback Yield	0.01%
Shareholder Yield	0.01%
Earnings Yield	2.11%
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a